Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
Neutralizing antibodies for respiratory syncytial virus (RSV) can reduce disease in hospitalized children, but current options show limited efficacy. Here, the authors isolate potent single-domain antibodies from llamas that recognize the prefusion conformation of RSV F and prevent RSV replication i...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms14158 |